Mira PharmaceuticalsMIRA
13F holders, Q2 2025 (June 30)20holders +1
5new positions
4sold out
$1.21avg. 13F price*
At the end of Q2 2025, 20 institutions reported holding Mira Pharmaceuticals Inc. (MIRA) in their 13F filings, up 1 from Q1 2025. 5 opened new positions and 4 sold out. The largest holders were Cross Staff Investments Inc ($435K), Geode Capital Management, LLC ($164K) and Vanguard Group Inc. ($143K).
- Company
- Mira Pharmaceuticals Inc.
- CUSIP
- 60458C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $98K |
| Exits | 4 | $42K |
All 13F filers, Q1 2025 → Q2 2025: 91,517 shares bought and 59,915 shares sold, net +31,602 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Cross Staff Investments Inc | 0.32% | Reduce -1.1% | 359,401 | $435K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.1% | 135,295 | $164K |
| Vanguard Group Inc. | 0.00% | No change | 117,824 | $143K |
| Suncoast Equity Management | 0.01% | No change | 103,289 | $125K |
| State Street Corp. | 0.00% | No change | 49,100 | $59K |
| J.W. Cole Advisors, Inc. | 0.00% | Add +1.6% | 40,655 | $49K |
| International Assets Investment Management, LLC | 0.00% | New | 35,000 | $42K |
| Commonwealth Equity Services, LLC | 0.00% | Add +16.1% | 29,664 | $36K |
| Creative Planning | 0.00% | New | 22,599 | $27K |
| XTX Topco Ltd | 0.00% | New | 21,873 | $26K |
| First American Bank | 0.00% | No change | 20,000 | $24K |
| Two Sigma Investments, LP | 0.00% | Reduce -11.1% | 19,887 | $24K |
| Mariner, LLC | 0.00% | Add +43.5% | 16,500 | $20K |
| Northern Trust Corp. | 0.00% | No change | 13,595 | $16K |
| Cary Street Partners Financial LLC | 0.00% | No change | 10,000 | $12K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $2K |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +100.0% | 2,000 | $2K |
| Fortitude Family Office, LLC | 0.00% | New | 773 | $935 |
| UBS Group AG | 0.00% | New | 500 | $605 |
| Bank of America Corp. | 0.00% | Reduce -98.8% | 119 | $144 |
"% of holder's portfolio" is MIRA's weight in each manager's 13F, not the share of Mira Pharmaceuticals Inc. the manager owns.